Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study

Abstract Background Allogeneic stem cell transplantation (allo‐HSCT) is the ultimate cure for acute lymphoblastic leukemia (ALL). Aim This study was performed to compare the outcomes of ALL patients receiving busulfan (Bu) with cyclophosphamide (Cy)‐based or total body irradiation (TBI)‐based regime...

Full description

Bibliographic Details

Published in:	Cancer Reports
Main Authors:	Yu‐Hung Wang, Feng‐Ming Tien, Cheng‐Hong Tsai, Huai‐Hsuan Huang, Jia‐Hau Liu, Xiu‐Wen Liao, Jih‐Luh Tang, Ming Yao, Bor‐Sheng Ko
Format:	Article
Language:	English
Published:	Wiley 2022-03-01
Subjects:	acute lymphoblastic leukemia allogeneic transplantation busulfan conditioning chemotherapy Taiwan
Online Access:	https://doi.org/10.1002/cnr2.1488